Henry J. Fuchs, President, Worldwide R&D at BIOMARIN PHARMACEUTICAL INC (BMRN), sold 25,000 shares at $99.00 ($2.5M) on 2018-08-24, disclosed to the SEC on 2018-08-28.
Open-market sale of $2.5M BMRN by President, Worldwide R&D. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $99.00 | 12,500 | $1.2M | 49.7% |
| 2 | $100.00 | 12,500 | $1.3M | 50.3% |
| Total | $99.50 avg | 25,000 | $2.5M | 100% |
| Filing → |
| MRTX | SELL | 2022-02-14 | $1.4M | — | Filing → |
| MRTX | SELL | 2020-12-16 | $4.7M | — | Filing → |
| MRTX | SELL | 2020-08-11 | $1.6M | — | Filing → |